TELCON RF PHARMACEUTICAL. Inc. (200230.KQ) KOE

1,000.00

+3(+0.30%)

Updated at January 15 09:49AM

Currency In KRW

Valuation

Market Cap69.45B
Enterprise Value121.83B
P/E Ratio-1.05
PEG Ratio0.12
Price/Sales Ratio0.34
Price/Book Ratio0.35
Enterprise/Revenue0.33
Enterprise/EBITDA-0.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.77
Operating Margin0.03

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.42

Income Statement

Revenue37.87B
Revenue/Share1,234.09
Gross Profit10.31B
EBITDA-18.23B
Net Income-26.32B
Diluted EPS-2,224.63

Balance Sheet

Total Cash40.38B
Total Cash/Share1,141
Total Debt34.04B
Total Debt/Equity0.33
Current Ratio1
Book Value Per Share2,882.31

Price History

52-Week Change-79.34
52-Week High4,433.33
52-Week Low887
Moving Average 50 Days1,001.52
Moving Average 200 Days1,408.51

Statistics

Average Volume2.2M
Shares Outstanding14.86M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateDecember 10, 2024